In addition, the ratio of pathogenic/likely pathogenic alterations in POLE in the exonuclease domain was only 1.4% (7.3% in the TCGA), supporting the favorable prognosis of POLE-mutated endometrial carcinomas [4]. The gene discussed is POLE; the disease is endometrial carcinoma.